BioSpace News Archive

Orexo, a Swedih pharmaceutical company focused on improved pharmaceuticals and digital therapies, announced that it will partner with Lyfebulb, a patient empowerment platform, to work with substance abuse patients to identify unmet needs made more acute by the pandemic,

ChemoCentryx, Inc., (NASDAQ: CCXI) and Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced topline data from a forty-six (46) patient Phase II dose-ranging trial in the orphan kidney disorder, primary Focal Segmental Glomerulosclerosis (FSGS). The LUMINA-1 trial tested CCX140, an orally-administered selective inhibitor of the chemokine receptor known as CCR2, in primary FSGS subjects. In the study, CCX140

Neogen Corporation (NASDAQ: NEOG) announced today that is has launched an enhanced version of its Igenity ® Beef profile, a genomic test for commercial cattle. Last fall, Neogen announced a partnership with International Genetic Solutions (IGS) to put even more power behind Igenity Beef by leveraging IGS’s platform that ranks as the

Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the successful implementation of its Rapid Restart™ program. Launched over a month ago, Taconic was the first animal model provider in the industry to provide researchers with a program specifically designed to aid laboratories transitioning back to increased productivity. COVID-19 forced many institutions to discontinue critical research prog

Powerhouse tech companies Salesforce, a customer relationship management solution, and G2, the world’s leading business software and review platform, are joining forces as sponsors of the American Cancer Society’s 2020 Discovery Ball: Be Bold and Rise Up.

Kelyniam Global (OTC: KLYG), a maker of custom cranial implants, today announced results for its fourth quarter and full year ended December 31 , 2019. “Kelyniam achieved record sales in 2019, growing slightly over 2018’s strong performance,” said Ross Bjella , Kelyniam’s CEO. “This marks three years in a row with positive grow

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that it has initiated a Phase 1b /2 clinical study in patients undergoing bunionectomy of HTX-034, Hero

Wize Pharma , Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced that on May 13, 2020 , Bo

Advarra, the premier provider of institutional review board (IRB), institutional biosafety committee (IBC), research technology solutions, and quality and compliance consulting services announces virtual educational opportunities to support the research community, including topics to help sites, sponsors, and CROs through the coronavirus (COVID-19)

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, and Illumina Inc. (NASDAQ: ILMN), a global leader in next-generation sequencing platforms, today announced that they have settled their patent infringement action (“Action”) concerning Illumina’s U.S. Patent No. 9,493,831 (“‘831 Pate